nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—Loss of consciousness—Docetaxel—stomach cancer	0.00123	0.00178	CcSEcCtD
Darifenacin—Cough—Docetaxel—stomach cancer	0.00122	0.00177	CcSEcCtD
Darifenacin—Hypersensitivity—Irinotecan—stomach cancer	0.00122	0.00176	CcSEcCtD
Darifenacin—Syncope—Capecitabine—stomach cancer	0.00122	0.00176	CcSEcCtD
Darifenacin—Hypertension—Docetaxel—stomach cancer	0.00121	0.00175	CcSEcCtD
Darifenacin—Infestation NOS—Epirubicin—stomach cancer	0.00121	0.00175	CcSEcCtD
Darifenacin—Infestation—Epirubicin—stomach cancer	0.00121	0.00175	CcSEcCtD
Darifenacin—Bronchitis—Doxorubicin—stomach cancer	0.00121	0.00174	CcSEcCtD
Darifenacin—Palpitations—Capecitabine—stomach cancer	0.0012	0.00173	CcSEcCtD
Darifenacin—Arthralgia—Docetaxel—stomach cancer	0.0012	0.00172	CcSEcCtD
Darifenacin—Loss of consciousness—Capecitabine—stomach cancer	0.00119	0.00172	CcSEcCtD
Darifenacin—Asthenia—Irinotecan—stomach cancer	0.00119	0.00171	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00119	0.00171	CcSEcCtD
Darifenacin—Cough—Capecitabine—stomach cancer	0.00119	0.00171	CcSEcCtD
Darifenacin—Stomatitis—Epirubicin—stomach cancer	0.00118	0.0017	CcSEcCtD
Darifenacin—Urinary tract infection—Epirubicin—stomach cancer	0.00118	0.0017	CcSEcCtD
Darifenacin—Hypertension—Capecitabine—stomach cancer	0.00117	0.00169	CcSEcCtD
Darifenacin—Hypersensitivity—Fluorouracil—stomach cancer	0.00117	0.00169	CcSEcCtD
Darifenacin—Dry mouth—Docetaxel—stomach cancer	0.00117	0.00168	CcSEcCtD
Darifenacin—Sweating—Epirubicin—stomach cancer	0.00116	0.00167	CcSEcCtD
Darifenacin—Arthralgia—Capecitabine—stomach cancer	0.00116	0.00167	CcSEcCtD
Darifenacin—Confusional state—Docetaxel—stomach cancer	0.00116	0.00167	CcSEcCtD
Darifenacin—Pharyngitis—Methotrexate—stomach cancer	0.00115	0.00166	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00115	0.00166	CcSEcCtD
Darifenacin—Urinary tract disorder—Methotrexate—stomach cancer	0.00115	0.00165	CcSEcCtD
Darifenacin—Anaphylactic shock—Docetaxel—stomach cancer	0.00115	0.00165	CcSEcCtD
Darifenacin—Oedema—Docetaxel—stomach cancer	0.00115	0.00165	CcSEcCtD
Darifenacin—Weight increased—Doxorubicin—stomach cancer	0.00114	0.00165	CcSEcCtD
Darifenacin—Urethral disorder—Methotrexate—stomach cancer	0.00114	0.00164	CcSEcCtD
Darifenacin—Infection—Docetaxel—stomach cancer	0.00114	0.00164	CcSEcCtD
Darifenacin—Sinusitis—Epirubicin—stomach cancer	0.00114	0.00164	CcSEcCtD
Darifenacin—Diarrhoea—Irinotecan—stomach cancer	0.00113	0.00163	CcSEcCtD
Darifenacin—Dry mouth—Capecitabine—stomach cancer	0.00113	0.00163	CcSEcCtD
Darifenacin—Shock—Docetaxel—stomach cancer	0.00113	0.00162	CcSEcCtD
Darifenacin—Nervous system disorder—Docetaxel—stomach cancer	0.00112	0.00162	CcSEcCtD
Darifenacin—Pruritus—Fluorouracil—stomach cancer	0.00112	0.00162	CcSEcCtD
Darifenacin—Infestation NOS—Doxorubicin—stomach cancer	0.00112	0.00162	CcSEcCtD
Darifenacin—Infestation—Doxorubicin—stomach cancer	0.00112	0.00162	CcSEcCtD
Darifenacin—Visual impairment—Methotrexate—stomach cancer	0.00112	0.00161	CcSEcCtD
Darifenacin—Confusional state—Capecitabine—stomach cancer	0.00112	0.00161	CcSEcCtD
Darifenacin—Tachycardia—Docetaxel—stomach cancer	0.00112	0.00161	CcSEcCtD
Darifenacin—Skin disorder—Docetaxel—stomach cancer	0.00111	0.0016	CcSEcCtD
Darifenacin—Oedema—Capecitabine—stomach cancer	0.00111	0.0016	CcSEcCtD
Darifenacin—Infection—Capecitabine—stomach cancer	0.0011	0.00159	CcSEcCtD
Darifenacin—Erythema multiforme—Methotrexate—stomach cancer	0.0011	0.00158	CcSEcCtD
Darifenacin—Dizziness—Irinotecan—stomach cancer	0.0011	0.00158	CcSEcCtD
Darifenacin—Stomatitis—Doxorubicin—stomach cancer	0.00109	0.00158	CcSEcCtD
Darifenacin—Shock—Capecitabine—stomach cancer	0.00109	0.00157	CcSEcCtD
Darifenacin—Rhinitis—Epirubicin—stomach cancer	0.00109	0.00157	CcSEcCtD
Darifenacin—Urinary tract infection—Doxorubicin—stomach cancer	0.00109	0.00157	CcSEcCtD
Darifenacin—Nervous system disorder—Capecitabine—stomach cancer	0.00109	0.00157	CcSEcCtD
Darifenacin—Eye disorder—Methotrexate—stomach cancer	0.00109	0.00157	CcSEcCtD
Darifenacin—Diarrhoea—Fluorouracil—stomach cancer	0.00109	0.00157	CcSEcCtD
Darifenacin—Tachycardia—Capecitabine—stomach cancer	0.00108	0.00156	CcSEcCtD
Darifenacin—Pharyngitis—Epirubicin—stomach cancer	0.00108	0.00156	CcSEcCtD
Darifenacin—Skin disorder—Capecitabine—stomach cancer	0.00108	0.00155	CcSEcCtD
Darifenacin—Sweating—Doxorubicin—stomach cancer	0.00107	0.00155	CcSEcCtD
Darifenacin—Urinary tract disorder—Epirubicin—stomach cancer	0.00107	0.00155	CcSEcCtD
Darifenacin—Hyperhidrosis—Capecitabine—stomach cancer	0.00107	0.00155	CcSEcCtD
Darifenacin—Oedema peripheral—Epirubicin—stomach cancer	0.00107	0.00154	CcSEcCtD
Darifenacin—Urethral disorder—Epirubicin—stomach cancer	0.00107	0.00154	CcSEcCtD
Darifenacin—Angiopathy—Methotrexate—stomach cancer	0.00105	0.00152	CcSEcCtD
Darifenacin—Vomiting—Irinotecan—stomach cancer	0.00105	0.00152	CcSEcCtD
Darifenacin—Sinusitis—Doxorubicin—stomach cancer	0.00105	0.00152	CcSEcCtD
Darifenacin—Dizziness—Fluorouracil—stomach cancer	0.00105	0.00151	CcSEcCtD
Darifenacin—Visual impairment—Epirubicin—stomach cancer	0.00105	0.00151	CcSEcCtD
Darifenacin—Mediastinal disorder—Methotrexate—stomach cancer	0.00105	0.00151	CcSEcCtD
Darifenacin—Rash—Irinotecan—stomach cancer	0.00104	0.00151	CcSEcCtD
Darifenacin—Dermatitis—Irinotecan—stomach cancer	0.00104	0.00151	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00104	0.0015	CcSEcCtD
Darifenacin—Headache—Irinotecan—stomach cancer	0.00104	0.0015	CcSEcCtD
Darifenacin—Insomnia—Docetaxel—stomach cancer	0.00104	0.00149	CcSEcCtD
Darifenacin—Erythema multiforme—Epirubicin—stomach cancer	0.00103	0.00148	CcSEcCtD
Darifenacin—Dyspnoea—Docetaxel—stomach cancer	0.00102	0.00147	CcSEcCtD
Darifenacin—Somnolence—Docetaxel—stomach cancer	0.00102	0.00147	CcSEcCtD
Darifenacin—Mental disorder—Methotrexate—stomach cancer	0.00102	0.00147	CcSEcCtD
Darifenacin—Eye disorder—Epirubicin—stomach cancer	0.00102	0.00147	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00101	0.00146	CcSEcCtD
Darifenacin—Vomiting—Fluorouracil—stomach cancer	0.00101	0.00145	CcSEcCtD
Darifenacin—Rhinitis—Doxorubicin—stomach cancer	0.00101	0.00145	CcSEcCtD
Darifenacin—Dyspepsia—Docetaxel—stomach cancer	0.00101	0.00145	CcSEcCtD
Darifenacin—Insomnia—Capecitabine—stomach cancer	0.001	0.00145	CcSEcCtD
Darifenacin—Rash—Fluorouracil—stomach cancer	0.001	0.00144	CcSEcCtD
Darifenacin—Dermatitis—Fluorouracil—stomach cancer	0.001	0.00144	CcSEcCtD
Darifenacin—Pharyngitis—Doxorubicin—stomach cancer	0.000999	0.00144	CcSEcCtD
Darifenacin—Headache—Fluorouracil—stomach cancer	0.000994	0.00143	CcSEcCtD
Darifenacin—Urinary tract disorder—Doxorubicin—stomach cancer	0.000994	0.00143	CcSEcCtD
Darifenacin—Oedema peripheral—Doxorubicin—stomach cancer	0.000991	0.00143	CcSEcCtD
Darifenacin—Dysgeusia—Methotrexate—stomach cancer	0.000991	0.00143	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000989	0.00143	CcSEcCtD
Darifenacin—Dyspnoea—Capecitabine—stomach cancer	0.000989	0.00143	CcSEcCtD
Darifenacin—Angiopathy—Epirubicin—stomach cancer	0.000987	0.00142	CcSEcCtD
Darifenacin—Urethral disorder—Doxorubicin—stomach cancer	0.000986	0.00142	CcSEcCtD
Darifenacin—Nausea—Irinotecan—stomach cancer	0.000984	0.00142	CcSEcCtD
Darifenacin—Mediastinal disorder—Epirubicin—stomach cancer	0.00098	0.00141	CcSEcCtD
Darifenacin—Pain—Docetaxel—stomach cancer	0.00098	0.00141	CcSEcCtD
Darifenacin—Constipation—Docetaxel—stomach cancer	0.00098	0.00141	CcSEcCtD
Darifenacin—Back pain—Methotrexate—stomach cancer	0.000979	0.00141	CcSEcCtD
Darifenacin—Dyspepsia—Capecitabine—stomach cancer	0.000976	0.00141	CcSEcCtD
Darifenacin—Visual impairment—Doxorubicin—stomach cancer	0.00097	0.0014	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000958	0.00138	CcSEcCtD
Darifenacin—Vision blurred—Methotrexate—stomach cancer	0.000953	0.00137	CcSEcCtD
Darifenacin—Mental disorder—Epirubicin—stomach cancer	0.000953	0.00137	CcSEcCtD
Darifenacin—Erythema multiforme—Doxorubicin—stomach cancer	0.000952	0.00137	CcSEcCtD
Darifenacin—Pain—Capecitabine—stomach cancer	0.000949	0.00137	CcSEcCtD
Darifenacin—Constipation—Capecitabine—stomach cancer	0.000949	0.00137	CcSEcCtD
Darifenacin—Feeling abnormal—Docetaxel—stomach cancer	0.000944	0.00136	CcSEcCtD
Darifenacin—Nausea—Fluorouracil—stomach cancer	0.000943	0.00136	CcSEcCtD
Darifenacin—Eye disorder—Doxorubicin—stomach cancer	0.00094	0.00136	CcSEcCtD
Darifenacin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000937	0.00135	CcSEcCtD
Darifenacin—Flatulence—Epirubicin—stomach cancer	0.000933	0.00135	CcSEcCtD
Darifenacin—Dysgeusia—Epirubicin—stomach cancer	0.000927	0.00134	CcSEcCtD
Darifenacin—Back pain—Epirubicin—stomach cancer	0.000916	0.00132	CcSEcCtD
Darifenacin—Feeling abnormal—Capecitabine—stomach cancer	0.000914	0.00132	CcSEcCtD
Darifenacin—Angiopathy—Doxorubicin—stomach cancer	0.000913	0.00132	CcSEcCtD
Darifenacin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000907	0.00131	CcSEcCtD
Darifenacin—Mediastinal disorder—Doxorubicin—stomach cancer	0.000907	0.00131	CcSEcCtD
Darifenacin—Abdominal pain—Docetaxel—stomach cancer	0.000906	0.00131	CcSEcCtD
Darifenacin—Vision blurred—Epirubicin—stomach cancer	0.000892	0.00129	CcSEcCtD
Darifenacin—Cough—Methotrexate—stomach cancer	0.000883	0.00127	CcSEcCtD
Darifenacin—Mental disorder—Doxorubicin—stomach cancer	0.000882	0.00127	CcSEcCtD
Darifenacin—Abdominal pain—Capecitabine—stomach cancer	0.000877	0.00126	CcSEcCtD
Darifenacin—Flatulence—Doxorubicin—stomach cancer	0.000863	0.00124	CcSEcCtD
Darifenacin—Arthralgia—Methotrexate—stomach cancer	0.000861	0.00124	CcSEcCtD
Darifenacin—Dysgeusia—Doxorubicin—stomach cancer	0.000858	0.00124	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000855	0.00123	CcSEcCtD
Darifenacin—Syncope—Epirubicin—stomach cancer	0.000849	0.00122	CcSEcCtD
Darifenacin—Back pain—Doxorubicin—stomach cancer	0.000847	0.00122	CcSEcCtD
Darifenacin—Hypersensitivity—Docetaxel—stomach cancer	0.000844	0.00122	CcSEcCtD
Darifenacin—Palpitations—Epirubicin—stomach cancer	0.000837	0.00121	CcSEcCtD
Darifenacin—Confusional state—Methotrexate—stomach cancer	0.000833	0.0012	CcSEcCtD
Darifenacin—Loss of consciousness—Epirubicin—stomach cancer	0.000832	0.0012	CcSEcCtD
Darifenacin—Cough—Epirubicin—stomach cancer	0.000826	0.00119	CcSEcCtD
Darifenacin—Anaphylactic shock—Methotrexate—stomach cancer	0.000826	0.00119	CcSEcCtD
Darifenacin—Vision blurred—Doxorubicin—stomach cancer	0.000826	0.00119	CcSEcCtD
Darifenacin—Asthenia—Docetaxel—stomach cancer	0.000822	0.00118	CcSEcCtD
Darifenacin—Infection—Methotrexate—stomach cancer	0.00082	0.00118	CcSEcCtD
Darifenacin—Hypertension—Epirubicin—stomach cancer	0.000817	0.00118	CcSEcCtD
Darifenacin—Hypersensitivity—Capecitabine—stomach cancer	0.000817	0.00118	CcSEcCtD
Darifenacin—Pruritus—Docetaxel—stomach cancer	0.000811	0.00117	CcSEcCtD
Darifenacin—Nervous system disorder—Methotrexate—stomach cancer	0.00081	0.00117	CcSEcCtD
Darifenacin—Arthralgia—Epirubicin—stomach cancer	0.000806	0.00116	CcSEcCtD
Darifenacin—Skin disorder—Methotrexate—stomach cancer	0.000802	0.00116	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000801	0.00115	CcSEcCtD
Darifenacin—Hyperhidrosis—Methotrexate—stomach cancer	0.000798	0.00115	CcSEcCtD
Darifenacin—Asthenia—Capecitabine—stomach cancer	0.000796	0.00115	CcSEcCtD
Darifenacin—Dry mouth—Epirubicin—stomach cancer	0.000788	0.00114	CcSEcCtD
Darifenacin—Syncope—Doxorubicin—stomach cancer	0.000786	0.00113	CcSEcCtD
Darifenacin—Pruritus—Capecitabine—stomach cancer	0.000785	0.00113	CcSEcCtD
Darifenacin—Diarrhoea—Docetaxel—stomach cancer	0.000784	0.00113	CcSEcCtD
Darifenacin—Confusional state—Epirubicin—stomach cancer	0.000779	0.00112	CcSEcCtD
Darifenacin—Palpitations—Doxorubicin—stomach cancer	0.000774	0.00112	CcSEcCtD
Darifenacin—Oedema—Epirubicin—stomach cancer	0.000773	0.00111	CcSEcCtD
Darifenacin—Anaphylactic shock—Epirubicin—stomach cancer	0.000773	0.00111	CcSEcCtD
Darifenacin—Loss of consciousness—Doxorubicin—stomach cancer	0.00077	0.00111	CcSEcCtD
Darifenacin—Infection—Epirubicin—stomach cancer	0.000768	0.00111	CcSEcCtD
Darifenacin—Cough—Doxorubicin—stomach cancer	0.000764	0.0011	CcSEcCtD
Darifenacin—Shock—Epirubicin—stomach cancer	0.00076	0.0011	CcSEcCtD
Darifenacin—Diarrhoea—Capecitabine—stomach cancer	0.000759	0.00109	CcSEcCtD
Darifenacin—Nervous system disorder—Epirubicin—stomach cancer	0.000758	0.00109	CcSEcCtD
Darifenacin—Dizziness—Docetaxel—stomach cancer	0.000758	0.00109	CcSEcCtD
Darifenacin—Hypertension—Doxorubicin—stomach cancer	0.000756	0.00109	CcSEcCtD
Darifenacin—Tachycardia—Epirubicin—stomach cancer	0.000754	0.00109	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000752	0.00108	CcSEcCtD
Darifenacin—Skin disorder—Epirubicin—stomach cancer	0.000751	0.00108	CcSEcCtD
Darifenacin—Hyperhidrosis—Epirubicin—stomach cancer	0.000747	0.00108	CcSEcCtD
Darifenacin—Insomnia—Methotrexate—stomach cancer	0.000747	0.00108	CcSEcCtD
Darifenacin—Arthralgia—Doxorubicin—stomach cancer	0.000746	0.00108	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000741	0.00107	CcSEcCtD
Darifenacin—Dyspnoea—Methotrexate—stomach cancer	0.000736	0.00106	CcSEcCtD
Darifenacin—Somnolence—Methotrexate—stomach cancer	0.000734	0.00106	CcSEcCtD
Darifenacin—Dizziness—Capecitabine—stomach cancer	0.000733	0.00106	CcSEcCtD
Darifenacin—Dry mouth—Doxorubicin—stomach cancer	0.000729	0.00105	CcSEcCtD
Darifenacin—Vomiting—Docetaxel—stomach cancer	0.000728	0.00105	CcSEcCtD
Darifenacin—Dyspepsia—Methotrexate—stomach cancer	0.000727	0.00105	CcSEcCtD
Darifenacin—Rash—Docetaxel—stomach cancer	0.000722	0.00104	CcSEcCtD
Darifenacin—Dermatitis—Docetaxel—stomach cancer	0.000722	0.00104	CcSEcCtD
Darifenacin—Confusional state—Doxorubicin—stomach cancer	0.000721	0.00104	CcSEcCtD
Darifenacin—Headache—Docetaxel—stomach cancer	0.000718	0.00103	CcSEcCtD
Darifenacin—Oedema—Doxorubicin—stomach cancer	0.000715	0.00103	CcSEcCtD
Darifenacin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000715	0.00103	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000713	0.00103	CcSEcCtD
Darifenacin—Infection—Doxorubicin—stomach cancer	0.00071	0.00102	CcSEcCtD
Darifenacin—Pain—Methotrexate—stomach cancer	0.000706	0.00102	CcSEcCtD
Darifenacin—Vomiting—Capecitabine—stomach cancer	0.000705	0.00102	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000704	0.00101	CcSEcCtD
Darifenacin—Shock—Doxorubicin—stomach cancer	0.000703	0.00101	CcSEcCtD
Darifenacin—Nervous system disorder—Doxorubicin—stomach cancer	0.000701	0.00101	CcSEcCtD
Darifenacin—Rash—Capecitabine—stomach cancer	0.000699	0.00101	CcSEcCtD
Darifenacin—Insomnia—Epirubicin—stomach cancer	0.000699	0.00101	CcSEcCtD
Darifenacin—Dermatitis—Capecitabine—stomach cancer	0.000699	0.00101	CcSEcCtD
Darifenacin—Tachycardia—Doxorubicin—stomach cancer	0.000698	0.00101	CcSEcCtD
Darifenacin—Headache—Capecitabine—stomach cancer	0.000695	0.001	CcSEcCtD
Darifenacin—Skin disorder—Doxorubicin—stomach cancer	0.000694	0.001	CcSEcCtD
Darifenacin—Hyperhidrosis—Doxorubicin—stomach cancer	0.000691	0.000996	CcSEcCtD
Darifenacin—Dyspnoea—Epirubicin—stomach cancer	0.000689	0.000993	CcSEcCtD
Darifenacin—Somnolence—Epirubicin—stomach cancer	0.000687	0.00099	CcSEcCtD
Darifenacin—Nausea—Docetaxel—stomach cancer	0.00068	0.000981	CcSEcCtD
Darifenacin—Feeling abnormal—Methotrexate—stomach cancer	0.00068	0.000981	CcSEcCtD
Darifenacin—Dyspepsia—Epirubicin—stomach cancer	0.00068	0.000981	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000675	0.000973	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000667	0.000962	CcSEcCtD
Darifenacin—Pain—Epirubicin—stomach cancer	0.000661	0.000953	CcSEcCtD
Darifenacin—Constipation—Epirubicin—stomach cancer	0.000661	0.000953	CcSEcCtD
Darifenacin—Nausea—Capecitabine—stomach cancer	0.000659	0.00095	CcSEcCtD
Darifenacin—Abdominal pain—Methotrexate—stomach cancer	0.000653	0.000941	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000651	0.000939	CcSEcCtD
Darifenacin—Insomnia—Doxorubicin—stomach cancer	0.000647	0.000932	CcSEcCtD
Darifenacin—Dyspnoea—Doxorubicin—stomach cancer	0.000637	0.000919	CcSEcCtD
Darifenacin—Feeling abnormal—Epirubicin—stomach cancer	0.000637	0.000918	CcSEcCtD
Darifenacin—Somnolence—Doxorubicin—stomach cancer	0.000636	0.000916	CcSEcCtD
Darifenacin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000632	0.000911	CcSEcCtD
Darifenacin—Dyspepsia—Doxorubicin—stomach cancer	0.000629	0.000907	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000617	0.00089	CcSEcCtD
Darifenacin—Constipation—Doxorubicin—stomach cancer	0.000611	0.000881	CcSEcCtD
Darifenacin—Pain—Doxorubicin—stomach cancer	0.000611	0.000881	CcSEcCtD
Darifenacin—Abdominal pain—Epirubicin—stomach cancer	0.000611	0.000881	CcSEcCtD
Darifenacin—Hypersensitivity—Methotrexate—stomach cancer	0.000608	0.000877	CcSEcCtD
Darifenacin—Asthenia—Methotrexate—stomach cancer	0.000592	0.000854	CcSEcCtD
Darifenacin—Feeling abnormal—Doxorubicin—stomach cancer	0.000589	0.000849	CcSEcCtD
Darifenacin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000585	0.000843	CcSEcCtD
Darifenacin—Pruritus—Methotrexate—stomach cancer	0.000584	0.000842	CcSEcCtD
Darifenacin—Hypersensitivity—Epirubicin—stomach cancer	0.000569	0.000821	CcSEcCtD
Darifenacin—Abdominal pain—Doxorubicin—stomach cancer	0.000565	0.000815	CcSEcCtD
Darifenacin—Diarrhoea—Methotrexate—stomach cancer	0.000565	0.000814	CcSEcCtD
Darifenacin—Asthenia—Epirubicin—stomach cancer	0.000554	0.000799	CcSEcCtD
Darifenacin—Pruritus—Epirubicin—stomach cancer	0.000547	0.000788	CcSEcCtD
Darifenacin—Dizziness—Methotrexate—stomach cancer	0.000546	0.000787	CcSEcCtD
Darifenacin—Diarrhoea—Epirubicin—stomach cancer	0.000529	0.000762	CcSEcCtD
Darifenacin—Hypersensitivity—Doxorubicin—stomach cancer	0.000527	0.000759	CcSEcCtD
Darifenacin—Vomiting—Methotrexate—stomach cancer	0.000525	0.000757	CcSEcCtD
Darifenacin—Rash—Methotrexate—stomach cancer	0.000521	0.000751	CcSEcCtD
Darifenacin—Dermatitis—Methotrexate—stomach cancer	0.00052	0.00075	CcSEcCtD
Darifenacin—Headache—Methotrexate—stomach cancer	0.000517	0.000746	CcSEcCtD
Darifenacin—Asthenia—Doxorubicin—stomach cancer	0.000513	0.00074	CcSEcCtD
Darifenacin—Dizziness—Epirubicin—stomach cancer	0.000511	0.000737	CcSEcCtD
Darifenacin—Pruritus—Doxorubicin—stomach cancer	0.000506	0.000729	CcSEcCtD
Darifenacin—Vomiting—Epirubicin—stomach cancer	0.000491	0.000708	CcSEcCtD
Darifenacin—Nausea—Methotrexate—stomach cancer	0.00049	0.000707	CcSEcCtD
Darifenacin—Diarrhoea—Doxorubicin—stomach cancer	0.000489	0.000705	CcSEcCtD
Darifenacin—Rash—Epirubicin—stomach cancer	0.000487	0.000702	CcSEcCtD
Darifenacin—Dermatitis—Epirubicin—stomach cancer	0.000487	0.000702	CcSEcCtD
Darifenacin—Headache—Epirubicin—stomach cancer	0.000484	0.000698	CcSEcCtD
Darifenacin—Dizziness—Doxorubicin—stomach cancer	0.000473	0.000682	CcSEcCtD
Darifenacin—Nausea—Epirubicin—stomach cancer	0.000459	0.000662	CcSEcCtD
Darifenacin—Vomiting—Doxorubicin—stomach cancer	0.000455	0.000655	CcSEcCtD
Darifenacin—Rash—Doxorubicin—stomach cancer	0.000451	0.00065	CcSEcCtD
Darifenacin—Dermatitis—Doxorubicin—stomach cancer	0.00045	0.000649	CcSEcCtD
Darifenacin—Headache—Doxorubicin—stomach cancer	0.000448	0.000646	CcSEcCtD
Darifenacin—Nausea—Doxorubicin—stomach cancer	0.000425	0.000612	CcSEcCtD
Darifenacin—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	5.43e-05	0.000177	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP2A6—stomach cancer	5.41e-05	0.000177	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	5.41e-05	0.000177	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PRKCB—stomach cancer	5.39e-05	0.000176	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—APC—stomach cancer	5.39e-05	0.000176	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6ST—stomach cancer	5.37e-05	0.000175	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	5.36e-05	0.000175	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—AKR1C3—stomach cancer	5.26e-05	0.000172	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—MAPK3—stomach cancer	5.16e-05	0.000168	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APC—stomach cancer	5.16e-05	0.000168	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—RHOA—stomach cancer	5.16e-05	0.000168	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—MTHFR—stomach cancer	5.15e-05	0.000168	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—RHOA—stomach cancer	5.14e-05	0.000168	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ENO1—stomach cancer	5.13e-05	0.000167	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—FADS1—stomach cancer	5.1e-05	0.000167	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—TYMP—stomach cancer	5.1e-05	0.000167	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—RHOA—stomach cancer	5.09e-05	0.000166	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SMAD4—stomach cancer	5.04e-05	0.000164	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SMAD4—stomach cancer	5.02e-05	0.000164	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6R—stomach cancer	5e-05	0.000163	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	4.99e-05	0.000163	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SMAD4—stomach cancer	4.97e-05	0.000162	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	4.97e-05	0.000162	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—MAPK3—stomach cancer	4.94e-05	0.000161	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	4.92e-05	0.000161	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—MAPK1—stomach cancer	4.91e-05	0.00016	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—EGFR—stomach cancer	4.91e-05	0.00016	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6R—stomach cancer	4.79e-05	0.000156	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FYN—stomach cancer	4.78e-05	0.000156	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SREBF2—stomach cancer	4.78e-05	0.000156	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FYN—stomach cancer	4.77e-05	0.000156	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CAV1—stomach cancer	4.75e-05	0.000155	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—APOA1—stomach cancer	4.74e-05	0.000155	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FYN—stomach cancer	4.72e-05	0.000154	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—RORA—stomach cancer	4.72e-05	0.000154	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—MAPK1—stomach cancer	4.7e-05	0.000153	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—EGFR—stomach cancer	4.7e-05	0.000153	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—PIK3CA—stomach cancer	4.69e-05	0.000153	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SERPINE1—stomach cancer	4.68e-05	0.000153	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—KRAS—stomach cancer	4.64e-05	0.000151	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CD44—stomach cancer	4.55e-05	0.000149	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	4.53e-05	0.000148	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RHOA—stomach cancer	4.52e-05	0.000148	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	4.51e-05	0.000147	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—PIK3CA—stomach cancer	4.49e-05	0.000147	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FGFR2—stomach cancer	4.49e-05	0.000147	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SERPINE1—stomach cancer	4.49e-05	0.000146	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FGFR2—stomach cancer	4.48e-05	0.000146	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NOS3—stomach cancer	4.47e-05	0.000146	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	4.47e-05	0.000146	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—KRAS—stomach cancer	4.44e-05	0.000145	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FGFR2—stomach cancer	4.43e-05	0.000145	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALDOB—stomach cancer	4.43e-05	0.000144	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RHOA—stomach cancer	4.33e-05	0.000141	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NOS3—stomach cancer	4.28e-05	0.00014	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—PIK3CA—stomach cancer	4.26e-05	0.000139	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ERBB2—stomach cancer	4.18e-05	0.000137	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PPARG—stomach cancer	4.18e-05	0.000136	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALOX5—stomach cancer	4.11e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IRS2—stomach cancer	4.11e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IRS2—stomach cancer	4.1e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—PIK3CA—stomach cancer	4.08e-05	0.000133	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IRS2—stomach cancer	4.06e-05	0.000133	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—DPYD—stomach cancer	4.05e-05	0.000132	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ERBB2—stomach cancer	4.01e-05	0.000131	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CAV1—stomach cancer	3.99e-05	0.00013	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOA1—stomach cancer	3.98e-05	0.00013	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CAV1—stomach cancer	3.98e-05	0.00013	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL8—stomach cancer	3.97e-05	0.000129	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOA1—stomach cancer	3.97e-05	0.000129	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—HRAS—stomach cancer	3.94e-05	0.000129	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CAV1—stomach cancer	3.94e-05	0.000129	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOA1—stomach cancer	3.93e-05	0.000128	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CDKN1B—stomach cancer	3.87e-05	0.000126	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPP2R1A—stomach cancer	3.87e-05	0.000126	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL8—stomach cancer	3.8e-05	0.000124	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PRKCB—stomach cancer	3.8e-05	0.000124	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTP1—stomach cancer	3.79e-05	0.000124	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PRKCB—stomach cancer	3.78e-05	0.000124	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6ST—stomach cancer	3.78e-05	0.000123	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—HRAS—stomach cancer	3.77e-05	0.000123	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—stomach cancer	3.77e-05	0.000123	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6ST—stomach cancer	3.77e-05	0.000123	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ALB—stomach cancer	3.76e-05	0.000123	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PRKCB—stomach cancer	3.75e-05	0.000122	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—HMOX1—stomach cancer	3.74e-05	0.000122	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6ST—stomach cancer	3.73e-05	0.000122	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CDKN1B—stomach cancer	3.71e-05	0.000121	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCND1—stomach cancer	3.7e-05	0.000121	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—JUN—stomach cancer	3.69e-05	0.00012	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APC—stomach cancer	3.63e-05	0.000119	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APC—stomach cancer	3.62e-05	0.000118	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—stomach cancer	3.61e-05	0.000118	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—NOS3—stomach cancer	3.6e-05	0.000117	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MMP9—stomach cancer	3.59e-05	0.000117	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APC—stomach cancer	3.59e-05	0.000117	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTT1—stomach cancer	3.58e-05	0.000117	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CDKN1A—stomach cancer	3.58e-05	0.000117	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCND1—stomach cancer	3.54e-05	0.000116	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.54e-05	0.000115	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—JUN—stomach cancer	3.53e-05	0.000115	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—TYMS—stomach cancer	3.53e-05	0.000115	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK8—stomach cancer	3.49e-05	0.000114	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTM1—stomach cancer	3.49e-05	0.000114	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	3.48e-05	0.000114	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	3.47e-05	0.000113	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.44e-05	0.000112	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MMP9—stomach cancer	3.44e-05	0.000112	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	3.43e-05	0.000112	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CDKN1A—stomach cancer	3.42e-05	0.000112	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6R—stomach cancer	3.37e-05	0.00011	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6R—stomach cancer	3.36e-05	0.00011	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ENO1—stomach cancer	3.35e-05	0.000109	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK8—stomach cancer	3.34e-05	0.000109	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6R—stomach cancer	3.33e-05	0.000109	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	3.31e-05	0.000108	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—EGFR—stomach cancer	3.31e-05	0.000108	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	3.3e-05	0.000108	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—EGFR—stomach cancer	3.3e-05	0.000108	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—stomach cancer	3.29e-05	0.000107	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ERCC2—stomach cancer	3.28e-05	0.000107	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	3.27e-05	0.000107	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—EGFR—stomach cancer	3.27e-05	0.000107	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—VEGFA—stomach cancer	3.22e-05	0.000105	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STAT3—stomach cancer	3.19e-05	0.000104	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	3.16e-05	0.000103	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	3.16e-05	0.000103	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	3.15e-05	0.000103	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	3.15e-05	0.000103	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—KRAS—stomach cancer	3.13e-05	0.000102	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	3.12e-05	0.000102	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	3.12e-05	0.000102	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—KRAS—stomach cancer	3.12e-05	0.000102	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—KRAS—stomach cancer	3.09e-05	0.000101	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—VEGFA—stomach cancer	3.09e-05	0.000101	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MTHFR—stomach cancer	3.08e-05	0.000101	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STAT3—stomach cancer	3.06e-05	9.97e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK3—stomach cancer	3.05e-05	9.95e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RHOA—stomach cancer	3.05e-05	9.95e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RHOA—stomach cancer	3.04e-05	9.91e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NOS3—stomach cancer	3.02e-05	9.84e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RHOA—stomach cancer	3.01e-05	9.82e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NOS3—stomach cancer	3.01e-05	9.81e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NOS3—stomach cancer	2.98e-05	9.72e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CD44—stomach cancer	2.97e-05	9.71e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MYC—stomach cancer	2.96e-05	9.68e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK3—stomach cancer	2.92e-05	9.53e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK1—stomach cancer	2.9e-05	9.47e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—EGFR—stomach cancer	2.9e-05	9.46e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	2.87e-05	9.38e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	2.86e-05	9.35e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CAV1—stomach cancer	2.84e-05	9.28e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MYC—stomach cancer	2.84e-05	9.27e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOA1—stomach cancer	2.84e-05	9.26e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	2.84e-05	9.26e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ERBB2—stomach cancer	2.82e-05	9.21e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ERBB2—stomach cancer	2.81e-05	9.18e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ERBB2—stomach cancer	2.78e-05	9.09e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK1—stomach cancer	2.78e-05	9.07e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—EGFR—stomach cancer	2.78e-05	9.06e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—KRAS—stomach cancer	2.74e-05	8.94e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL8—stomach cancer	2.67e-05	8.73e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL8—stomach cancer	2.67e-05	8.7e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HRAS—stomach cancer	2.66e-05	8.67e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HRAS—stomach cancer	2.65e-05	8.65e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL8—stomach cancer	2.64e-05	8.62e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HRAS—stomach cancer	2.62e-05	8.56e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—KRAS—stomach cancer	2.62e-05	8.56e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	2.61e-05	8.53e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	2.6e-05	8.5e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	2.58e-05	8.42e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—stomach cancer	2.54e-05	8.3e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—stomach cancer	2.54e-05	8.28e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.53e-05	8.26e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	2.52e-05	8.21e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—stomach cancer	2.51e-05	8.2e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARG—stomach cancer	2.5e-05	8.16e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCND1—stomach cancer	2.49e-05	8.13e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—JUN—stomach cancer	2.49e-05	8.12e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCND1—stomach cancer	2.48e-05	8.11e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTP1—stomach cancer	2.48e-05	8.1e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—JUN—stomach cancer	2.48e-05	8.09e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCND1—stomach cancer	2.46e-05	8.03e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—JUN—stomach cancer	2.45e-05	8.01e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—HMOX1—stomach cancer	2.45e-05	7.99e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TP53—stomach cancer	2.43e-05	7.95e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MMP9—stomach cancer	2.42e-05	7.9e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MMP9—stomach cancer	2.41e-05	7.87e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	2.41e-05	7.87e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	2.41e-05	7.87e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	2.4e-05	7.84e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MMP9—stomach cancer	2.39e-05	7.8e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	2.38e-05	7.77e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK8—stomach cancer	2.35e-05	7.68e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK8—stomach cancer	2.35e-05	7.66e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TP53—stomach cancer	2.33e-05	7.61e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HRAS—stomach cancer	2.33e-05	7.6e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK8—stomach cancer	2.32e-05	7.58e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—TYMS—stomach cancer	2.31e-05	7.53e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTM1—stomach cancer	2.28e-05	7.44e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ALB—stomach cancer	2.25e-05	7.34e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HRAS—stomach cancer	2.23e-05	7.28e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—stomach cancer	2.23e-05	7.27e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—VEGFA—stomach cancer	2.17e-05	7.09e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—VEGFA—stomach cancer	2.17e-05	7.07e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STAT3—stomach cancer	2.15e-05	7.02e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—NOS3—stomach cancer	2.15e-05	7.02e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—VEGFA—stomach cancer	2.14e-05	7e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STAT3—stomach cancer	2.14e-05	7e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ERCC2—stomach cancer	2.14e-05	7e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—stomach cancer	2.13e-05	6.97e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STAT3—stomach cancer	2.12e-05	6.93e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK3—stomach cancer	2.06e-05	6.71e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK3—stomach cancer	2.05e-05	6.69e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK3—stomach cancer	2.03e-05	6.62e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CA—stomach cancer	2.02e-05	6.6e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MTHFR—stomach cancer	2.02e-05	6.58e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MYC—stomach cancer	2e-05	6.52e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MYC—stomach cancer	1.99e-05	6.5e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MYC—stomach cancer	1.97e-05	6.44e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—stomach cancer	1.97e-05	6.42e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK1—stomach cancer	1.96e-05	6.38e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—EGFR—stomach cancer	1.96e-05	6.38e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK1—stomach cancer	1.95e-05	6.36e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—EGFR—stomach cancer	1.95e-05	6.36e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK1—stomach cancer	1.93e-05	6.3e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—EGFR—stomach cancer	1.93e-05	6.3e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CAV1—stomach cancer	1.86e-05	6.07e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOA1—stomach cancer	1.85e-05	6.05e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KRAS—stomach cancer	1.85e-05	6.03e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KRAS—stomach cancer	1.84e-05	6.01e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KRAS—stomach cancer	1.82e-05	5.95e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.7e-05	5.54e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	1.69e-05	5.52e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	1.68e-05	5.47e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TP53—stomach cancer	1.64e-05	5.36e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TP53—stomach cancer	1.64e-05	5.34e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARG—stomach cancer	1.63e-05	5.33e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TP53—stomach cancer	1.62e-05	5.29e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.57e-05	5.12e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HRAS—stomach cancer	1.56e-05	5.11e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HRAS—stomach cancer	1.55e-05	5.06e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—stomach cancer	1.5e-05	4.9e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—stomach cancer	1.5e-05	4.89e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—stomach cancer	1.48e-05	4.84e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALB—stomach cancer	1.47e-05	4.8e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NOS3—stomach cancer	1.41e-05	4.59e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—stomach cancer	1.29e-05	4.2e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.21e-05	3.95e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CA—stomach cancer	7.91e-06	2.58e-05	CbGpPWpGaD
